Enlivex Announces Issuance of Israeli Patent Covering Allocetra Derived from Pooled Donor Cells
Enlivex Therapeutics Ltd Nes-Ziona, Israel, March 08, 2022 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy com...